Buserelin treatment of advanced prostatic carcinoma. Long-term follow-up of antitumor responses and improved quality of life.

C A Presant; M S Soloway; S S Klioze; A Yakabow; S N Presant; R G Mendez; P S Kennedy; M R Wyres; V L Naessig; B Todd

doi:10.1002/1097-0142(19870515)59:10<1713::aid-cncr2820591006>3.0.co;2-8

Buserelin treatment of advanced prostatic carcinoma. Long-term follow-up of antitumor responses and improved quality of life.

NobleID: NI3P69W08R60S40
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/3B105ABC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/3B105ABC.svg?ark=w1%2F20260515%2F3B105ABC&value=id)](https://nobleid.org/work/w1/20260515/3B105ABC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Buserelin treatment of advanced prostatic carcinoma. Long-term follow-up of antitumor responses and improved quality of life.

NobleID: NI3P69W08R60S40
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/3B105ABC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/3B105ABC.svg?ark=w1%2F20260515%2F3B105ABC&value=id)](https://nobleid.org/work/w1/20260515/3B105ABC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work